Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.

Abstract

BACKGROUND:

Neurogenic orthostatic hypotension, a sustained decrease in blood pressure upon standing, is caused by autonomic nervous system failure and characterized by an insufficient increase in heart rate needed to maintain blood pressure upon standing. In this case, neurogenic orthostatic hypotension symptoms preceded a diagnosis of Parkinson disease. A diagnosis of underlying neurogenic orthostatic hypotension significantly changed the course of treatment for this patient.

CASE PRESENTATION:

An 84-year-old woman was referred to a cardiologist by her primary care practitioner for evaluation of exertional dyspnea and chest pain upon walking a few feet. Her medical history included hypertension, hypothyroidism, and osteoarthritis. Based on her continued symptoms, the patient underwent 2 cardiac catheterizations for coronary artery stenosis. After the catheterizations, exertional dyspnea and chest pain continued, and subsequently, dysphagia to solid foods and episodic dizziness developed. Orthostatic evaluation showed a supine blood pressure of 150/80 mmHg with a heart rate of 70 beats per min. Upon standing for 3 min, the patient's blood pressure decreased to 110/74 mmHg with a heart rate of 76 beats per min. The diagnostic criteria for orthostatic hypotension were met, and the lack of an adequate compensatory heart rate increase upon standing was consistent with a neurogenic cause (ie, neurogenic orthostatic hypotension), which was supported by tilt-table testing results. Although nonpharmacologic treatments were initially successful, episodes of lightheadedness, chest pain, and dyspnea upon standing became more frequent, and the patient was prescribed droxidopa (200 mg; 3 times daily). Droxidopa significantly improved her symptoms, with the patient reporting resolution of her chest pain and significant improvement of dyspnea and dizziness. She was diagnosed with Parkinson disease approximately 6 months later.

CONCLUSIONS:

This case highlights the importance of evaluating and identifying potential causes of symptoms of cardiovascular disease when persistent symptoms do not improve after cardiac interventions. This case complements findings demonstrating that signs of autonomic failure, such as neurogenic orthostatic hypotension, may precede the motor symptoms of Parkinson disease. Importantly, this case provides real-world evidence for the efficacy of droxidopa to treat the symptoms of neurogenic orthostatic hypotension, after an appropriate diagnosis.

• Authors: Sameh K Mobarek
• Journal: BMC cardiovascular disorders (BMC Cardiovasc Disord) Vol. 20 Issue 1 Pg. 54 (02 04 2020) ISSN: 1471-2261 [Electronic] England
• PMID: 32019498 (Publication Type: Case Reports, Research Support, Non-U.S. Gov't)

Chemical References

• Antiparkinson Agents
• Droxidopa

Topics

• Aged, 80 and over
• Antiparkinson Agents (therapeutic use)
• Blood Pressure
• Chest Pain (diagnosis, etiology, physiopathology)
• Coronary Artery Disease (complications, diagnostic imaging, physiopathology, therapy)
• Coronary Stenosis (complications, diagnostic imaging, physiopathology, therapy)
• Droxidopa (therapeutic use)
• Dyspnea (diagnosis, etiology, physiopathology)
• Female
• Humans
• Hypotension, Orthostatic (diagnosis, etiology, physiopathology)
• Parkinson Disease (complications, diagnosis, drug therapy, physiopathology)
• Percutaneous Coronary Intervention
• Posture
• Treatment Outcome